It is likely that patients with a lower platelet count had more severe portal hypertension and that the vascular derangements secondary to portal hypertension lead to the decreased expression of the receptors for proangiogenic factors like FGFR1, FGFR2, and VEGFR2. The gene discussed is FGFR1; the disease is portal hypertension.